Chiropractic Economics

NOVEMBER 13, 2024

Cash flow for the nine-month period ended Sept. 30, 2024, includes $5.3 million from operations and the net proceeds of the sales of clinics offset by ongoing IT capex and the $2.0 million first quarter 2024 repayment of the line of credit to JP Morgan Chase. Through this facility, we have retained immediate access to $20 million through Feb.

Joints

iMatrix

DECEMBER 18, 2024

billion people, were on social media, which is expected to increase to 6 billion by 2027. It is a comprehensive and customized social media marketing strategy tailored to chiropractic practices. As of 2024, over 86% of the global population, or 5.17

Chiropractic

Chiropractic Economics

JUNE 6, 2025

The stock repurchase program does not obligate the company to acquire any particular amount of common stock, has a termination date of June 3, 2027, and may be suspended or discontinued at any time. About The Joint Corp. The Joint Corp.

Joints

Chiropractic Economics

MAY 8, 2025

The Joint Corp, the US’s largest franchisor of chiropractic care through The Joint Chiropractic network, has been named the Official Chiropractic Partner of Texas Christian University (TCU) Athletics in Fort Worth, Texas, for a three-year term through 2027. in a company press release.

Joints

Practice Promotions

JULY 27, 2025

This alignment with client well-being bridges the gap between rehabilitation and ongoing wellness. Kevin’s inspiration stems from market demand observed in the broader health and wellness industry, which is projected to reach $3 trillion in the U.S.

Physical therapy

Orthogate

MARCH 14, 2025

This is a funded 2-year position working as an orthopedic surgery research fellow. Your work will be based at TRIA Orthopedics in the Minneapolis/St. This research fellowship is directed towards orthopedic trauma and orthopedic value-based research.

Clinic

OrthoSpineNews

JULY 14, 2025

Proposed transaction creates the broadest, most flexible portfolio of orthopedic robotics and navigation technologies to meet surgeons’ needs Acquisition expected to be neutral to adjusted earnings per share in 2025 – 2027 and accretive thereafter and to contribute to revenue growth beginning in 2027 WARSAW, Ind.

Adjustment